Cesium Chloride pH Cancer Treatment

Cesium chloride can assist in a holistic cancer treatment. Cesium chloride will not cure cancer alone but in combination with other herbs, juices and therapies, cesium chloride will boost cancer treatment effectiveness.

Cesium chloride is the salt form of the element cesium. Cesium is a rare, naturally occurring element of alkali metal similar in chemical structure to lithium, sodium, and potassium.

1984 studies report that cesium chloride is effective against cancer by changing the acidic pH range of the cancer cell towards weak alkalinity in which the survival of the cancer cell is endangered, and the formation of acidic and toxic materials, normally formed in cancer cells, is neutralized and eliminated. This approach is termed the high pH therapy.

In another 1984 research, predetermined amounts of cesium chloride or carbonate, zinc gluconate and vitamin A were used together to alter growth of colon carcinoma implants in mice. Data showed that the use of these compounds in a treatment protocol is responsible for repression of tumor growth. It was also found that cesium is only moderately toxic and exerts salubrious effects which could be gainfully investigated for application in the treatment of certain psychological disorders and some tumor.

A research conducted by Hellfried Sartori, also in 1984, reported a total of 50 patients treated over a 3-year period with cesium chloride. The majority of the patients had been unresponsive to previous maximal modalities of cancer treatment and were considered terminal cases. The treatment consisted of cesium chloride, some vitamins, minerals, chelating agents, and salts of selenium, potassium, and magnesium. In addition, a special diet was also instituted. There was an impressive 50% recovery of various cancers (i.e. cancer of unknown primary, breast, colon, prostate, pancreas, lung, liver, lymphoma, ewing sarcoma of the pelvis and adeno-cancer of the gallbladder) by the cesium chloride therapy employed. There was a 26% and 24% death within the initial 2 weeks and 12 months of treatment, respectively. A consistent finding in these patients was the disappearance of pain within the initial 3 days of cesium chloride treatment. The small number of autopsies made showed the absence of cancer cells in most cases.

In a 2003 report, cesium levels were measured to determine exposure to an alternative medical treatment. This was based on cesium levels reported from two patients who were administered cesium chloride in conjunction with aloe vera as part of an alternative cancer treatment. High level of cesium were found in brain, liver, kidney, bile, gastric content, and whole blood collected at autopsy as compared to reference levels. The highest cesium chloride concentrations were found in the liver, followed by the kidney, and then the brain. The high accumulation in the liver suggests that hepatotoxicity from cesium might be an initial presenting symptom in cesium chloride poisoning.

In a 2007 study it was found that cesium chloride may have therapeutic effects against prostate cancer but may also induce acute toxicities dependent on the dosage administered.

A 2010 review on available material on cesium salts and their applications on medicine concluded that the presence of cesium in the cell does not guarantee high pH of its content, and there is no clinical evidence to support the claims that cancer cells are vulnerable to cesium.

In addition to cancer therapy, a U.S. Patent has been issued on the use of cesium chloride as a nerve stimulant.

pH Therapy

The pH therapy was created by Keith Brewer in 1984 using Otto Warburg‘s Nobel Prize winning 1931 research that cancer thrives in acidic conditions. Using Warburg’s theory, Brewer was able to create a cost efficient treatment protocol for cancer and was able to treat 30 patients with various cancers through cesium.

In Brewer’s 1984 study, it was shown that potassium, rubidium, and especially cesium are most efficiently taken up by cancer cells. This uptake was enhanced by Vitamins A and C as well as salts of zinc and selenium. The quantity of cesium taken up was sufficient to raise the cell to the 8 pH range where cell mitosis ceases and the life of the cell is short. Tests on mice fed cesium and rubidium showed marked shrinkage in the tumor masses within 2 weeks. In addition, the mice showed none of the side effects of cancer. Another test have been carried out on over 30 humans. In each case the tumor masses disappeared. Also all pains and effects associated with cancer disappeared within 12 to 36 hours.

The use of cesium chloride should not be confused with the use of radioactive cesium 137, an artificial isotope produced in nuclear reactors.

Lack of Survival Studies Regarding the Usage of Cesium for Cancer

Brewer used cesium chloride with other leading anti-cancer products in his studies so it is difficult to determine whether it was liquid cesium or the other components of the combined therapy that was the cause of the increased survival of the 30 patients he treated. There is also no mention of how long those 30 patients survived for.

Sartori also used a combination of cesium chloride and other components. Furthermore, Sartori’s medical license was revoked in Maryland, Virginia, Pennsylvania, Texas, and Washington State after relying on “unvalidated techniques” in a manner that was medically inappropriate. A news article reported that four cancer patients in Perth died after two weeks of Sartori’s treatment. This involved the administration of cesium chloride, magnesium sulphate, and potassium chloride. A fifth patient, who also underwent the same treatment, stopped after five days following unbearable pain and being told to control the pain with his mind.

Hans Nieper, who also advocated the use of liquid cesium chloride as well as other anti-cancer products, was well-known for not providing any follow up survival statistics.

Cesium Chloride Precaution

The toxic dose for cesium chloride is 135 g. Though relatively safe, mild toxicities may occur when using cesium. This can be seen through gastrointestinal distress, hypotension, syncope, numbness, or tingling of the lips. Total cesium intakes of 6 g per day have been found to produce severe hypokalemia, hypomagnesemia, prolonged QTc interval, episodes of polymorphic ventricular tachycardia, with or without torsade de pointes, and even acute heart arrest. However, full information on its acute and chronic toxicity is not sufficiently known.

Buy Cesium Chloride Products Online

Cesium Chloride
http://bit.ly/fIgeGa

Cesium Chloride Research Links

Pharmacological and toxicological investigations of cesium.
http://www.ncbi.nlm.nih.gov/pubmed/6543004?dopt=Abstract

The response of colon carcinoma in mice to cesium, zinc and vitamin A.
http://www.ncbi.nlm.nih.gov/pubmed/6522429?dopt=Abstract

Cesium therapy in cancer patients.
http://www.ncbi.nlm.nih.gov/pubmed/6522427?dopt=Abstract

The high pH therapy for cancer tests on mice and humans.
http://www.ncbi.nlm.nih.gov/pubmed/6522424?dopt=Abstract

Effect of cesium and ethanol on tumor bearing rats.
http://www.ncbi.nlm.nih.gov/pubmed/6395134?dopt=Abstract

Effect of alkali metal salts on Sarcoma I in A/J mice.
http://www.ncbi.nlm.nih.gov/pubmed/6275211?dopt=Abstract

Nutrients and cancer: an introduction to cesium therapy.
http://www.ncbi.nlm.nih.gov/pubmed/6522434?dopt=Abstract

Cesium Science.
http://cancer-coverup.com/fighters/cesium-science.htm

Clinical effects of cesium intake.
http://www.ncbi.nlm.nih.gov/pubmed/19655100

Assessing the therapeutic and toxicological effects of cesium chloride following administration to nude mice bearing PC-3 or LNCaP prostate cancer xenografts.
http://www.ncbi.nlm.nih.gov/pubmed/17294190

Acquired long QT syndrome and monomorphic ventricular tachycardia after alternative treatment with cesium chloride for brain cancer.
http://www.ncbi.nlm.nih.gov/pubmed/15301336

Blood and tissue concentration of cesium after exposure to cesium chloride: a report of two cases.
http://www.ncbi.nlm.nih.gov/pubmed/12958400

Cesium toxicity: a case of self-treatment by alternate therapy gone awry.
http://www.ncbi.nlm.nih.gov/pubmed/12548155